According to filings with the U.S. Securities and Exchange Commission, Veritas Aortic Solutions has raised $12 Million in new Seed funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Cedars-Sinai Intellectual Property Company, and inQB8

About Veritas Aortic Solutions
Veritas Aortic Solutions is a privately held medical device company committed to improving outcomes for patients with Aortic Disease. The company’s flagship technology, the Veritas Transcatheter Valved Aortic Root Conduit (TVARC) is a single permanent implant that combines a bioprosthetic aortic valve, ascending aortic graft, and the company’s proprietary Chameleon Eye coronary perfusion ports and is designed to seal-off the diseased or damaged part of the aorta and restore healthy blood flow to the coronaries and the rest of the body. Veritas was founded and incubated within inQB8 Medical Technologies, LLC and spun-out as a standalone company in late 2025 to provide a comprehensive solution to pathologies affecting the most critical areas of the heart, including the aortic root, coronaries and ascending aorta.

To learn more, visit https://www.veritasaortic.com/
Linkedin: https://www.linkedin.com/company/veritas-aortic/

Contact:
Brent Ratz, Chief Executive Officer
https://www.linkedin.com/in/brent-ratz/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.